←Back to Expert Scholars
Translational Medicine / 转化医学Theranostics, PSMA and DOTATATE
Scott Tagawa
MD, MS
🏢Weill Cornell Medicine🌐USA
Professor of Medicine and Urology
70
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Scott Tagawa is a medical oncologist with extensive clinical trials experience in prostate cancer radioligand and radioimmunotherapy including actinium-225 and lutetium-177 based therapies. He has led early-phase alpha-emitter trials. His work advances next-generation PSMA-targeted therapeutics.
Share:
🧪Research Fields 研究领域
PSMA radioimmunotherapy
actinium-225 therapy
prostate cancer trials
antibody-drug conjugates
advanced prostate cancer
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Scott Tagawa 的研究动态
Follow Scott Tagawa's research updates
留下邮箱，当我们发布与 Scott Tagawa（Weill Cornell Medicine）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment